Retinoic acid determines life span of leukemic cells by inducing antagonistic apoptosis-regulatory programs
- 31 August 2005
- journal article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 37 (8) , 1696-1708
- https://doi.org/10.1016/j.biocel.2005.03.003
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Principles for modulation of the nuclear receptor superfamilyNature Reviews Drug Discovery, 2004
- Therapeutic potential of antisense Bcl‐2 as a chemosensitizer for cancer therapyCancer, 2004
- p53 Upregulates Death Receptor 4 Expression through an Intronic p53 Binding SiteCancer Research, 2004
- Bcl-2 Family Member Bfl-1/A1 Sequesters Truncated Bid to Inhibit Its Collaboration with Pro-apoptotic Bak or BaxJournal of Biological Chemistry, 2002
- All trans retinoic acid in acute promyelocytic leukemiaOncogene, 2001
- Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-κB inhibitionOncogene, 2000
- Structural Basis of BFL-1 for Its Interaction with BAX and Its Anti-apoptotic Action in Mammalian and Yeast CellsPublished by Elsevier ,2000
- The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappa B that blocks TNFalpha -induced apoptosisGenes & Development, 1999
- An Induced Proximity Model for Caspase-8 ActivationJournal of Biological Chemistry, 1998
- The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death DomainImmunity, 1997